908 Devices: director Brown sells $317,400 of common stock By Investing.com

Christopher D. Brown, a Director at 908 Devices Inc. (), recently sold shares of the company’s common stock. The transactions occurred on September 2, 2026.

Mr. Brown disposed of 30,000 shares of common stock for a total value of $317,400. The shares were sold at prices ranging from $10.33 to $10.97 per share. This sale was executed under a Rule 10b5-1 trading plan, which Mr. Brown adopted on November 24, 2025.

Following these transactions, Christopher D. Brown beneficially owns 775,559 shares of 908 Devices Inc. common stock.The insider sale comes as the stock trades at $10.05, showing remarkable momentum with a 91% year-to-date return and 83% gain over the past year. According to InvestingPro analysis, the stock appears overvalued relative to its Fair Value estimate. For deeper insights into MASS’s valuation and access to exclusive Pro Research Reports covering 1,400+ US stocks, visit InvestingPro.

In other recent news, 908 Devices reported stronger-than-expected revenue for the second quarter of 2026, with a 23% increase from the previous year, reaching $16.1 million. This figure surpassed Wall Street’s forecast of $15.22 million. However, the company posted a wider-than-expected adjusted loss per share of $0.32, compared to the anticipated loss of $0.15. Despite the loss, 908 Devices raised its full-year sales outlook, indicating a positive shift in its future expectations. Stifel responded to these developments by raising its price target for 908 Devices shares to $12.00 from $10.00, while maintaining a Buy rating. The firm highlighted the company’s second-quarter performance and the upward revision of its full-year guidance as key reasons for this adjustment. Stifel also noted that 908 Devices is benefiting from favorable government policies and priorities. These recent developments reflect the company’s ongoing efforts to improve its financial performance and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.